EpCAM is a transmembrane glycoprotein that is overexpressed on the surface of various carcinoma cells. One of the mechanisms, of how EpCAM promotes cancer growth, is regulated intramembrane proteolysis, during which the intracellular domain of EpCAM (EpIC) is released in the cytosol. EpIC then forms a signaling complex with proteins FHL2, β-catenin, and Lef-1. In the nucleus, the signaling complex activates the transcription of oncogenes, which promote cell proliferation. To obtain a better understanding of this process, we wanted to prepare the components of the complex and analyze the interaction between them. Therefore, we expressed recombinant β-catenin, FHL2, Lef-1, and EpIC in E. coli and purify them. We established new protocols for the expression and purification of FHL2 and Lef-1. We also optimized already established protocols for the expression and purification of β-catenin and different variants of sfGFP fusions of EpIC. Because FHL2 is prone to the formation of inclusion bodies, we expressed the protein as a fusion with different solubility-enhancement tags. sfGFP proved to be the best choice since it provides high yields and enables the subsequent removal of the tag during purification. After we prepared purified proteins, we analyzed the interaction between them using SEC and cross-linking. The analysis with SEC showed the presence of the interaction between FHL2 and β-catenin, however, there was no interaction between EpIC and other proteins. After cross-linking we observed the interaction between FHL2 and β-catenin, and β-catenin and Lef-1. The results also showed the interaction of EpIC with β-catenin and FHL2. Besides the already performed analysis, the protocols for the preparation of individual components of the complex enables further research into their roles and interactions between them.
|